PANACEABIO Intraday Analysis...

PANACEABIO Share Price

Open 121.00 Change Price %
High 122.00 1 Day 1.90 1.64
Low 116.20 1 Week 4.25 3.74
Close 118.00 1 Month 1.30 1.11
Volume 35561 1 Year -35.50 -23.13
52 Week High 156.95
52 Week Low 83.70
PANACEABIO Important Levels
Resistance 2 123.38
Resistance 1 121.16
Pivot 118.73
Support 1 114.84
Support 2 112.62
NSE INDIA Most Active Stocks
UNITECH 4.55 -4.21%
ADANIPOWER 31.10 6.69%
CROMPGREAV 68.35 -10.42%
SUNTV 492.60 12.80%
HCC 39.75 -1.97%
HCC 39.75 -1.97%
ASHOKLEY 77.20 3.35%
JPASSOCIAT 7.65 1.32%
HINDALCO 174.50 3.41%
SBIN 256.90 1.10%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
RAJRAYON 0.30 20.00%
LOTUSEYE 31.95 19.66%
RAJTV 68.90 19.31%
SOMICONVEY 59.75 18.43%
ARIHANT 60.80 17.83%
VISASTEEL 19.35 13.16%
SUNTV 492.60 12.80%
MVL 0.45 12.50%
MVL 0.45 12.50%
More..
NSE INDIA Top Losers Stocks
FCSSOFT 0.25 -16.67%
AUSTRAL 0.30 -14.29%
CROMPGREAV 68.35 -10.42%
SHYAMCENT 9.90 -9.59%
PRAKASH 43.45 -9.57%
NICCO 0.50 -9.09%
SPYL 1.85 -7.50%
DREDGECORP 381.70 -6.37%
TVTODAY 293.80 -6.25%
BALLARPUR 15.65 -6.01%
More..

Panacea Biotec Limited (NSE: PANACEABIO)

PANACEABIO Technical Analysis 3
As on 5th Dec 2016 PANACEABIO Share Price closed @ 118.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 110.21 & Buy for SHORT-TERM with Stoploss of 112.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
PANACEABIO Target for December
1st Target up-side 150.5
2nd Target up-side 167.25
3rd Target up-side 184
1st Target down-side 102.7
2nd Target down-side 85.95
3rd Target down-side 69.2
PANACEABIO Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
PANACEABIO Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.panacea-biotec.com
PANACEABIO Address
PANACEABIO
Mohan Co-operative Industrial Estate
B-1 Extn./ A-27
New Delhi, 110044
India
Phone: 91 11 2694 5270
Fax: 91 11 4167 9081
PANACEABIO Latest News
Panacea Biotec: A Turnaround Story   Financial Express   - 04th Feb 15
Panacea Biotec bags Rs. 83 cr order to supply EasyFive-TT vaccine   Hindu Business Line   - 04th Feb 15
Panacea Biotec Announces Collaboration with Rising Pharmaceuticals Inc.   Hindu Business Line   - 19th Dec 14
Panacea Biotec and Apotex form alliance   VC Circle   - 12th Dec 14
Panacea Biotec plans to sell hospital in Gurgaon   VC Circle   - 26th Nov 14
Panacea Biotec Ltd to announce Q2 results on October 31, 2014   Equity Bulls   - 18th Oct 14
Panacea Biotec - Approval of Restructuring proposal under CDR system   Moneycontrol.com   - 29th Sep 14
Panacea Biotec plans to raise up to $42M   VC Circle   - 24th Jul 14
Panacea Biotec bags Unicef order   Hindu Business Line   - 13th Feb 14
Panacea Biotec - Credit Rating   Moneycontrol.com   - 31st Oct 12
Interactive Technical Analysis Chart Panacea Biotec Limited ( PANACEABIO NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Panacea Biotec Limited
PANACEABIO Business Profile
Panacea Biotec is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 620.47 crore.The company has reported a standalone sales of Rs 110.09 crore and a Net Loss of Rs 56.27 crore for the quarter ended Sep 2013.The company management includes Soshil Kumar Jain - Chairman, Ravinder Jain - Managing Director, Rajesh Jain - Joint Managing Director, Sandeep Jain - Joint Managing Director, Sumit Jain - Director, R L Narasimhan - Independent Director, N N Khamitkar - Independent Director, Sunil Kapoor - Independent Director, K M Lal - Independent Director, A N Saksena - Independent Director. It is listed on the BSE with a BSE Code of 531349 and the NSE with an NSE Code of PANACEABIO.Its Registered office is at Ambala-Chandigarh Highway , Lalru,Punjab - 140501.Their Registrars are Skyline Financial Services (p) Ltd.